Xiaomin Li

2.6k total citations
147 papers, 1.7k citations indexed

About

Xiaomin Li is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Xiaomin Li has authored 147 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 31 papers in Epidemiology and 30 papers in Immunology. Recurrent topics in Xiaomin Li's work include Cancer-related molecular mechanisms research (11 papers), interferon and immune responses (8 papers) and MicroRNA in disease regulation (8 papers). Xiaomin Li is often cited by papers focused on Cancer-related molecular mechanisms research (11 papers), interferon and immune responses (8 papers) and MicroRNA in disease regulation (8 papers). Xiaomin Li collaborates with scholars based in China, United States and Hong Kong. Xiaomin Li's co-authors include Yanxia Lu, Fan Zhang, Xuenong Li, Wenjuan Zhang, Zheying Zhang, Jianjun Yang, Guang-Fen Zhang, Yuhan Hu, Zuoyang Zhang and Lin Zheng and has published in prestigious journals such as Nature, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Xiaomin Li

131 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaomin Li China 20 829 409 320 195 195 147 1.7k
Lin Qiu China 21 676 0.8× 246 0.6× 180 0.6× 177 0.9× 129 0.7× 54 1.6k
Xiaomei Yang China 25 931 1.1× 258 0.6× 497 1.6× 392 2.0× 192 1.0× 119 2.2k
Hongkuan Fan United States 24 1.1k 1.3× 453 1.1× 931 2.9× 172 0.9× 281 1.4× 61 2.3k
Lixin Liu China 25 807 1.0× 168 0.4× 378 1.2× 102 0.5× 276 1.4× 64 1.9k
Jie Fan China 21 725 0.9× 244 0.6× 602 1.9× 231 1.2× 319 1.6× 57 2.1k
Eun‐Gyung Cho South Korea 27 770 0.9× 235 0.6× 211 0.7× 93 0.5× 120 0.6× 51 1.8k
Jacques R.R. Mathieu France 24 928 1.1× 285 0.7× 241 0.8× 153 0.8× 108 0.6× 59 1.9k
Christian R. Gómez United States 24 490 0.6× 164 0.4× 545 1.7× 213 1.1× 288 1.5× 54 1.7k
Yuesheng Huang China 27 964 1.2× 223 0.5× 161 0.5× 117 0.6× 582 3.0× 140 2.2k

Countries citing papers authored by Xiaomin Li

Since Specialization
Citations

This map shows the geographic impact of Xiaomin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaomin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaomin Li more than expected).

Fields of papers citing papers by Xiaomin Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaomin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaomin Li. The network helps show where Xiaomin Li may publish in the future.

Co-authorship network of co-authors of Xiaomin Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaomin Li. A scholar is included among the top collaborators of Xiaomin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaomin Li. Xiaomin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Song, Bo, S. Liang, Peng Wu, Xiaomin Li, & Qian Gong. (2025). Clinical application of PBMCs in breast cancer: detection, treatment evaluation and prognosis. Frontiers in Cell and Developmental Biology. 13. 1721106–1721106.
2.
Shen, Meifang, Yushu Wang, Lingpu Zhang, et al.. (2025). Ultrasound‐Triggered Cascade Delivery via Poly‐Oxaliplatin Nanoparticles for Immunotherapy. Advanced Functional Materials. 35(34). 5 indexed citations
3.
Zhang, Xu, Shiyu Wu, Yingtong Lin, et al.. (2025). Development of an Assay Evaluating the Inducible HIV‐1 Latent Reservoir Based on Reverse Transcription Droplet Digital PCR for Unspliced/Intact Viral RNA. Journal of Medical Virology. 97(3). e70295–e70295. 1 indexed citations
4.
Tong, Xiaowei, Yajian Li, Meifang Shen, et al.. (2025). Amplifying ER Stress via Biodegradable Pseudo‐Conjugated Polymer Nanoparticles for Enhanced Sonodynamic Immunotherapy. Advanced Functional Materials. 36(13).
5.
Zhang, Qi, Ting Huang, Xiaomin Li, et al.. (2024). Prognostic impact of enhanced CD96 expression on NK cells by TGF-β1 in AML. International Immunopharmacology. 141. 112958–112958. 3 indexed citations
6.
Ge, Meng‐Wei, Peng Liu, Haiyan Shi, et al.. (2024). Current Status of Nursing Home Distribution in China: A National Cross‐Sectional Study. Journal of Advanced Nursing. 81(6). 3268–3282. 1 indexed citations
7.
Xie, Yongpeng, et al.. (2024). Serum Mrp 8/14 as a Potential Biomarker for Predicting the Occurrence of Acute Respiratory Distress Syndrome Induced by Sepsis: A Retrospective Controlled Study. Journal of Inflammation Research. Volume 17. 2939–2949. 3 indexed citations
9.
10.
Chen, Ya‐Wen, et al.. (2023). Effects of amoxicillin exposure at different stages, doses and courses of pregnancy on adrenal development in fetal mice. Food and Chemical Toxicology. 175. 113754–113754. 4 indexed citations
12.
Zhao, Panpan, Xiaomin Li, Qiankun Yang, et al.. (2023). Malvidin alleviates mitochondrial dysfunction and ROS accumulation through activating AMPK-α/UCP2 axis, thereby resisting inflammation and apoptosis in SAE mice. Frontiers in Pharmacology. 13. 1038802–1038802. 30 indexed citations
13.
Wang, Yahui, Wenjuan Ouyang, Yalan Zhang, et al.. (2023). Safety, tolerability, pharmacokinetics and effects of diet on AD16, a novel neuroinflammatory inhibitor for Alzheimer’s disease: a randomized phase 1 study. BMC Medicine. 21(1). 459–459. 6 indexed citations
14.
Zhang, Ruizhi, et al.. (2023). Low-dose IL-2 therapy in autoimmune diseases: An update review. International Reviews of Immunology. 43(3). 113–137. 17 indexed citations
15.
Wang, Qiangqiang, Ju Zhang, Yue Xiao, et al.. (2021). <em>Caenorhabditis elegans</em> as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity. Journal of Visualized Experiments. 3 indexed citations
16.
Zhang, Wei, Xiaomin Li, Wenjuan Zhang, et al.. (2021). The LncRNA CASC11 Promotes Colorectal Cancer Cell Proliferation and Migration by Adsorbing miR-646 and miR-381-3p to Upregulate Their Target RAB11FIP2. Frontiers in Oncology. 11. 657650–657650. 12 indexed citations
17.
Xie, Yongpeng, et al.. (2019). Identification of DDX58 and CXCL10 as Potential Biomarkers in Acute Respiratory Distress Syndrome. DNA and Cell Biology. 38(12). 1444–1451. 11 indexed citations
18.
Sun, Zengxian, et al.. (2017). LncRNA‐TCONS_00034812 in cell proliferation and apoptosis of pulmonary artery smooth muscle cells and its mechanism. Journal of Cellular Physiology. 233(6). 4801–4814. 55 indexed citations
19.
Zhao, Jingjing, M. C. Fung, Yinyan Li, et al.. (2015). Tissue Transglutaminase‐Regulated Transformed Growth Factor‐β1 in the Parasite Links Schistosoma japonicum Infection with Liver Fibrosis. Mediators of Inflammation. 2015(1). 659378–659378. 9 indexed citations
20.
Chen, Zhengping, et al.. (2013). Animal biodistribution, safety and validation study of dopamine transporter PET imaging agent 18F-FECNT. 《核技术》(英文版). 20(1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026